An Open Label Randomized Controlled Trial of Ivermectin Plus Favipiravir-Based Standard of Care versus Favipiravir-Based Standard of Care for Treatment of Moderate COVID-19 in Thailand.
Phahol SarojvisutAnucha ApisarnthanarakKittiya JantarathaneewatOrnnicha SathitakornThanus PienthongChatchai MingmalairakDavid K WarrenDavid J WeberPublished in: Infection & chemotherapy (2022)
Clinicaltrials.gov Identifier: TCTR20220427005.